Valuing health-related quality of life among the Indian population: a protocol for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study.
health economics
health policy
public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
20 11 2020
20 11 2020
Historique:
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
20
3
2021
Statut:
epublish
Résumé
Quality-adjusted life year (QALY) has been recommended by the government as preferred outcome measure for Health Technology Assessment (HTA) in India. As country-specific health-related quality of life tariff values are essential for accurate measurement of QALYs, the government of India has commissioned the present study. The aim of this paper is to describe the methods for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study. Additionally, this study aspires to establish if the design of 10-time trade-off (TTO) blocks is enough to generate valid value sets. A cross-sectional survey using the EuroQol Group's Valuation Technology (EQ-VT) will be undertaken in a sample of 2700 respondents selected from six different states of India using a multistage stratified random sampling technique. The participants will be interviewed using computer-assisted personal interviewing technique. The TTO valuation will be done using 10 composite TTO (c-TTO) tasks and 7 discrete choice experiment (DCE) tasks. Hybrid modelling approach using both c-TTO and DCE data to estimate the potential value set will be applied. Values of all 3125 health states will be predicted using both the conventional EQ-VT design of 10 blocks of 10 TTO tasks, and an extended design of 18 blocks of 10 TTO tasks. The potential added value of the eight additional blocks in overall validity will be tested. The study will deliver value set for India and assess the adequacy of existing 10-blocks design to be able to correctly predict the values of all 3125 health states. The ethical approval has been obtained from Institutional Ethics Committee of PGIMER, Chandigarh, India. The anonymised EQ-5D-5L value set will be available for general use and in the HTAs commissioned by India's central HTA Agency.
Identifiants
pubmed: 33444194
pii: bmjopen-2020-039517
doi: 10.1136/bmjopen-2020-039517
pmc: PMC7682473
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e039517Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Bull World Health Organ. 1982;60(2):253-60
pubmed: 6980735
Value Health. 2019 Jan;22(1):23-30
pubmed: 30661630
Value Health. 2017 Mar;20(3):466-473
pubmed: 28292492
Pharmacoeconomics. 2016 Oct;34(10):993-1004
pubmed: 27084198
Pharmacoeconomics. 2017 Nov;35(11):1153-1165
pubmed: 28695543
Indian J Med Res. 2018 Sep;148(3):258-261
pubmed: 30425215
Med Decis Making. 2019 Jul;39(5):605-616
pubmed: 31257997
Health Econ. 2016 Feb;25 Suppl 1:140-61
pubmed: 26804361
Pharmacoeconomics. 2018 Jun;36(6):663-674
pubmed: 29460066
Med Care. 1995 Apr;33(4 Suppl):AS255-63
pubmed: 7723454
BMJ Open. 2019 Aug 18;9(8):e029067
pubmed: 31427330
Pharmacoecon Open. 2018 Mar;2(1):1-3
pubmed: 29464668
Pharmacoeconomics. 2020 Apr;38(4):413-425
pubmed: 31912325
BMJ Glob Health. 2017 Jun 26;2(2):e000259
pubmed: 29225927
Qual Life Res. 2016 Dec;25(12):2997-3008
pubmed: 27444779
Value Health. 2019 Jan;22(1):38-44
pubmed: 30661632
Soc Sci Med. 2002 Mar;54(6):919-29
pubmed: 11996025
Eur J Health Econ. 2013 Feb;14(1):57-66
pubmed: 21935715
Qual Life Res. 2017 May;26(5):1197-1208
pubmed: 27796774
Appl Health Econ Health Policy. 2015 Dec;13(6):595-613
pubmed: 26449485
Patient. 2018 Apr;11(2):235-247
pubmed: 29019161
Value Health Reg Issues. 2020 Sep;22:7-14
pubmed: 31683254
Value Health. 2014 Jan-Feb;17(1):77-83
pubmed: 24438720
Pharmacoeconomics. 2019 Sep;37(9):1165-1176
pubmed: 31161586
Pharmacoeconomics. 2018 Nov;36(11):1345-1353
pubmed: 30051267
Qual Life Res. 2019 Dec;28(12):3163-3175
pubmed: 31201730
Value Health. 2014 Jun;17(4):445-53
pubmed: 24969006
PLoS One. 2018 Dec 26;13(12):e0209344
pubmed: 30586400
Health Aff (Millwood). 2017 Nov;36(11):1866-1875
pubmed: 29137514
Glob Health Action. 2018;11(1):1527556
pubmed: 30326795